The FDA approved another set of denosumab biosimilars, Conexxence/Bomyntra (denosumab-bnht), expanding treatment options for ...

Dr. Surbhi Sidana discussed the topic of minimal residual disease during the CURE Educated Patient® Multiple Myeloma Summit.

Dr. Cesar Rodriguez discussed treatment advancements for multiple myeloma during a CURE Educated Patient® Summit.

Adam Perry shares the story of his journey discussing his diagnosis, treatment and the importance of early detection.

More than half of patients recently diagnosed with lymphoma or myeloma had clinically significant symptoms of anxiety or ...

This is Allison’s personal multiple myeloma story, and others may be different. Allison is a paid spokesperson for GSK.

Myeloma, or multiple myeloma, is a cancer affecting a particular type of blood cells, called plasma cells. Myeloma is most common in people over 60 and is characterized by the accumulation of ...

Bristol Myers Squibb Receives Positive CHMP Opinion for the Subcutaneous Formulation of Opdivo® (nivolumab) Across Multiple Solid Tumor Indications ...

In alpha-gal syndrome, the immune system overreacts to a sugar known as galactose-α-1,3-galactose, or "alpha-gal" for short.

Seek emergency medical care if you have a high fever, difficulty breathing, nausea or dizziness, or the rash is spreading rapidly. A rash is an area of skin that may be inflamed, irritated ...